PeptideNerds

FOXO4-DRI

Anti-Aging Research Only preliminary evidence Track This Protocol
Alejandro Reyes

Written by Alejandro Reyes

Founder & Lead Researcher

PN

Reviewed by Peptide Nerds Editorial · Updated April 2026

Key Takeaway

FOXO4-DRI is a senolytic peptide designed to selectively destroy senescent (zombie) cells that accumulate with aging and contribute to chronic inflammation.

Quick Facts
Type Anti-Aging
FDA Status Research Only
Evidence Level Preliminary
Typical Dose Experimental — no established human dose
Frequency Varies
Key Goals anti-aging

How it works

Disrupts the interaction between FOXO4 and p53 proteins in senescent cells, triggering apoptosis (cell death) specifically in damaged, non-functional cells.

Benefits

  • Selective senescent cell clearance
  • Potential tissue rejuvenation
  • Reduced age-related inflammation

Side effects

  • Very limited human data
  • Theoretical concern about destroying needed senescent cells

Dosing protocol

Typical Dose

Experimental — no established human dose

Frequency

Varies

Highly experimental. Very expensive. Limited availability.

Deeper on FOXO4-DRI

Full breakdowns of every part of the FOXO4-DRI research base.

What you will need

Basic supplies for reconstitution and subcutaneous injection.

This page contains affiliate links. Learn more

Get the FOXO4-DRI cheat sheet

Dosing quick-reference, key studies, and side effect management — in your inbox.

Get the FOXO4-DRI cheat sheet

Dosing quick-reference, key studies, and side effect management — in your inbox.

Related peptides

Looking for weight loss peptides? See our complete guide to the best peptides for weight loss or compare semaglutide vs tirzepatide .

Get the Peptide Starter Kit (free)

Quick-start guide to GLP-1 peptides, dosing basics, and what to ask your doctor.

Medical Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or a substitute for professional medical consultation, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide protocol.